Too few with stroke of the eye are treated to reduce future stroke
American Heart Association Meeting Report Poster TMP76 - Session: MP17
- Only one-third of 5,600 patients with retinal infarction, or stroke in the eye, underwent basic stroke work-up, and fewer than one in 10 were seen by a neurologist.
- One in 100 of the retinal infarction patients studied experienced another stroke within 90 days of their retinal infarction.
Embargoed until 3 p.m. Pacific Time/6 p.m. Eastern Time, Thursday, Jan. 25, 2018
This news release is featured in an embargoed media briefing at 3 p.m. PT Wed., Jan. 24, 2018
LOS ANGELES, Jan. 25, 2018 — Too few patients with retinal infarction, or loss of blood flow in the eye, are evaluated for stroke risk or seen by a neurologist, putting them at increased risk for another stroke, according to preliminary research presented at the American Stroke Association’s International Stroke Conference 2018, a world premier meeting dedicated to the science and treatment of cerebrovascular disease for researchers and clinicians.
The study showed that 1 in 100 patients in the study experienced an ischemic stroke within 90 days of a retinal infarction. In addition, among 5,688 individuals with retinal infarction, only one-third underwent basic testing, and fewer than one in 10 were seen by a neurologist. Within 90 days of symptoms, only 34 percent received cervical carotid imaging tests; 28.6 percent received heart-rhythm testing; 23.3 percent received echocardiography; and 8.4 percent were evaluated by a neurologist.
The findings illustrate the importance of expediting stroke evaluation testing for those who have experienced a retinal infarction, and for increased awareness and understanding about retinal infarctions and how they may signal future strokes. Retinal infarction may provide an opportunity in preventing stroke, explained lead study author Alexander Merkler, M.D., a neurologist at Weill Cornell Medical Center in New York.
“Our research tells us that we need to do a better job at evaluating patients with retinal infarction and making sure they receive the same standard of care tests that someone with a stroke in the brain would have,” said Merkler. “We need to work more closely with ophthalmologists to ensure patients with stroke of the eye get the appropriate tests and treatments in a timely manner.”
The findings are based on Medicare ophthalmology claims from between 2009 and 2015. Retinal infarction is a form of ischemic stroke in the eye. Symptoms can include blurred vision or vision loss, and tissue damage to the eye itself. Risk factors associated with stroke in the brain, including high blood pressure, high cholesterol, diabetes, and atrial fibrillation, are also associated with retinal infarction.
Stroke is the fifth-leading cause of death in the United States, accounting for one in every 20 deaths, but less is known about retinal infarction, which may go undetected and under-treated. Merkler plans to study the connections between retinal infarction and stroke using brain magnetic resonance imaging tests to see what’s happening.
Co-authors are Gina Gialdini, M.D.; Ajay Gupta, M.D.; and Hooman Kamel, M.D. Author disclosures are on the abstract.
Note: Scientific presentation is 5:30 p.m. Pacific Time, Thursday, Jan. 25, 2018.
Presentation location: Hall H
- Available downloadable video interviews with ASA expert and the study researcher, B-roll, animation and images related to this news release are on the right column of the release link https://newsroom.heart.org/news/too-few-with-stroke-of-the-eye-are-treated-to-reduce-future-stroke?preview=ea093d5aa3fefbb6b8f0517b9c87e4d7
- Stroke Prevention
- For more news at AHA International Stroke Conference 2018, follow us on Twitter @HeartNews #ISC18.
Statements and conclusions of study authors that are presented at American Heart Association scientific meetings are solely those of the study authors and do not necessarily reflect association policy or position. The association makes no representation or warranty as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.
About the American Stroke Association
The American Stroke Association is devoted to saving people from stroke — the No. 2 cause of death in the world and a leading cause of serious disability. We team with millions of volunteers to fund innovative research, fight for stronger public health policies and provide lifesaving tools and information to prevent and treat stroke. The Dallas-based association officially launched in 1998 as a division of the American Heart Association. To learn more or to get involved, call 1-888-4STROKE or visit StrokeAssociation.org. Follow us on Facebook and Twitter.
For Media Inquiries and AHA Spokesperson Perspective:
AHA News Media in Dallas: 214-706-1173
AHA News Media Office, Jan. 23-26, 2018 at the Los Angeles Convention Center: 213-743-6262
For Public Inquiries: 800-AHA-USA1 (242-8721)